Evidence map›Paper›PMID 40982003›Full record

ReviewArchives of toxicology2026

Regulated cell death in endometrial diseases: from molecular mechanisms to targeted therapies.

Duo Zi, Jing Sun, Na Zuo, Tingting Li, Junzhi Liang, Jia Hu, Zhijing Na, Hao Zhang, Lixia He, Da Li

Abstract readReview
PubMed Publisher
In one paragraph

Review in Archives of toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Duo Zi *Center of Reproductive Medicine, Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, China.
Jing Sun *Dandong Central Hospital, Dandong, China.
Na Zuo *Center of Reproductive Medicine, Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, China.
Tingting Li *Department of General Internal Medicine VIP Ward, Liaoning Cancer Hospital & Institute, Shenyang, China.
Junzhi LiangCenter of Reproductive Medicine, Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, China.
Jia HuCenter of Reproductive Medicine, Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, China.
Zhijing NaCenter of Reproductive Medicine, Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, China.
Hao ZhangDepartment of Ultrasound, Shengjing Hospital of China Medical University, Shenyang, China. zhanghao@sj-hospital.org.
Lixia HeCenter of Reproductive Medicine, Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, China. 13940126689@163.com.
Da LiCenter of Reproductive Medicine, Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, China. leeda@ymail.com.ORCID 0000-0002-4895-1185

Funding

Liaoning Revitalization Talents Program XLYC1907071National Key Research and Development Program 2024YFC2706900National Natural Science Foundation grant of China 82371647The Science Foundation for Outstanding Youth of Liaoning Province 2024JH3/50100023Wellcome Trust 202003
6 · The paper itself

Abstract

Regulated cell death (RCD) is a fundamental biological process essential for tissue homeostasis and disease regulation. Increasing evidence has demonstrated that RCD plays a pivotal role in the pathogenesis of uterine endometrial diseases, including endometriosis, abnormal decidualization, endometrial receptivity defects, and intrauterine adhesions. However, a comprehensive synthesis centered on the roles of RCD in endometrial diseases is still lacking. This review systematically summarizes the roles of various RCD pathways-apoptosis, autophagy, ferroptosis, pyroptosis, and cuproptosis-in endometrial diseases, emphasizing their interactions with hormonal signaling, molecular mechanisms in different endometrial cells, and cell-cell communication. It also evaluates therapeutic strategies targeting RCD, offering insights into potential interventions for diseases, such as endometriosis, intrauterine adhesion, and embryo implantation failure.

Indexed as

EndometriumRegulated Cell DeathUterine DiseasesAnimalsApoptosisAutophagyEndometriosisFemaleHumansMolecular Targeted TherapyPyroptosisSignal TransductionDecidualizationEndometrial diseasesEndometriosisHormonal signalingRegulated cell death

Identifiers

PMID40982003

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.